Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C25H46N.Cl |
| Molecular Weight | 396.092 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[Cl-].CCCCCCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1
InChI
InChIKey=SXPWTBGAZSPLHA-UHFFFAOYSA-M
InChI=1S/C25H46N.ClH/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-20-23-26(2,3)24-25-21-18-17-19-22-25;/h17-19,21-22H,4-16,20,23-24H2,1-3H3;1H/q+1;/p-1
| Molecular Formula | C25H46N |
| Molecular Weight | 360.6394 |
| Charge | 1 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | ClH |
| Molecular Weight | 36.461 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Cetalkonium chloride is a cationic quaternary ammonium surfactant, which is used for the treatment of mouth ulcers and sores (Bonjela trade name). It is also serves as an excipient for the purpose of long-term stabilization of ciclosporin ocular formulation, used in patients with dry eye syndrom (Ikervis trade name). The antibacterial properties of cetalkonium can be explained by its detergent character. Once applied, cetalkonium blocks the survival of biofilm forming bacterias.
Approval Year
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Curative | BONJELA Approved UseFor the relief of pain, discomfort and inflammation caused by common mouth ulcers, cold sores, denture and sore spots, as well as mouth ulcers, and sore spots due to orthodontic devices. To help to fight minor mouth infection and aid healing of sore spots and ulcers due to dentures and orthodontic devices. |
|||
| Inactive ingredient | IKERVIS Approved UseTreatment of severe keratitis in adult patients with dry eye disease, which has not improved despite treatment with tear substitutes. Launch Date2015 |
|||
| Primary | BONJELA Approved UseFor the relief of pain, discomfort and inflammation caused by common mouth ulcers, cold sores, denture and sore spots, as well as mouth ulcers, and sore spots due to orthodontic devices. To help to fight minor mouth infection and aid healing of sore spots and ulcers due to dentures and orthodontic devices. |
Doses
| Dose | Population | Adverse events |
|---|---|---|
0.1 % 1 times / day single, topical Studied dose Dose: 0.1 %, 1 times / day Route: topical Route: single Dose: 0.1 %, 1 times / day Sources: |
healthy, 28 to 55 years Health Status: healthy Age Group: 28 to 55 years Sex: M+F Sources: |
Other AEs: Contact dermatitis... |
AEs
| AE | Significance | Dose | Population |
|---|---|---|---|
| Contact dermatitis | 37.5% | 0.1 % 1 times / day single, topical Studied dose Dose: 0.1 %, 1 times / day Route: topical Route: single Dose: 0.1 %, 1 times / day Sources: |
healthy, 28 to 55 years Health Status: healthy Age Group: 28 to 55 years Sex: M+F Sources: |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Synthesis, self-aggregation and biological properties of alkylphosphocholine and alkylphosphohomocholine derivatives of cetyltrimethylammonium bromide, cetylpyridinium bromide, benzalkonium bromide (C16) and benzethonium chloride. | 2013-08 |
|
| Cationic reverse micelles create water with super hydrogen-bond-donor capacity for enzymatic catalysis: hydrolysis of 2-naphthyl acetate by alpha-chymotrypsin. | 2010-08-02 |
|
| Ammonium detection by formation of colored zebra-bands in a detecting tube. | 2010-06-15 |
|
| [Optimization of benzalkonium chloride concentration in 0.0015% tafluprost ophthalmic solution from the points of ocular surface safety and preservative efficacy]. | 2010-06 |
|
| Highlights on the capacities of "Gel-based" proteomics. | 2010-04-28 |
|
| Sorption of quaternary ammonium compounds to municipal sludge. | 2010-04 |
|
| Adsorptive removal of cationic surfactants from aqueous solutions onto high-area activated carbon cloth monitored by in situ UV spectroscopy. | 2010-02-15 |
|
| On the formation of new reverse micelles: a comparative study of benzene/surfactants/ionic liquids systems using UV-visible absorption spectroscopy and dynamic light scattering. | 2009-09-15 |
|
| Comparison of the ocular tolerability of a latanoprost cationic emulsion versus conventional formulations of prostaglandins: an in vivo toxicity assay. | 2009-08-25 |
|
| Characterization of multifunctional reverse micelles' interfaces using hemicyanines as molecular probes. II: Effect of the surfactant. | 2009-05-14 |
|
| Modulation of excited-state proton-transfer reactions of 7-hydroxy-4-methylcoumarin in ionic and nonionic reverse micelles. | 2009-05-14 |
|
| Two-dimensional separation of membrane proteins by 16-BAC-SDS-PAGE. | 2009 |
|
| 16-BAC/SDS-PAGE analysis of membrane proteins of yeast mitochondria purified by free flow electrophoresis. | 2009 |
|
| Effects of preparation and experimental conditions on removal of phenol by surfactant-modified zeolites. | 2008-11 |
|
| Micellization and interfacial behavior of binary and ternary mixtures of model cationic and nonionic surfactants in aqueous NaCl medium. | 2008-06-15 |
|
| Development of small, homogeneous pDNA particles condensed with mono-cationic detergents and encapsulated in a multifunctional envelope-type nano device. | 2008-06 |
|
| Two-dimensional electrophoresis with cationic detergents: a powerful tool for the proteomic analysis of myelin proteins. Part 2: analytical aspects. | 2008-03 |
|
| Reduction of quaternary ammonium-induced ocular surface toxicity by emulsions: an in vivo study in rabbits. | 2008-01-31 |
|
| Evaluation of two proteomics technologies used to screen the membrane proteomes of wild-type Corynebacterium glutamicum and an L-lysine-producing strain. | 2007-10 |
|
| Rapid screening of doping agents in human urine by vacuum MALDI-linear ion trap mass spectrometry. | 2007-08-01 |
|
| Effect of deaeration on the adsorption of a mixture of cetyltrimethylammonium bromide and cetyldimethylbenzylammonium chloride at the mercury/electrolyte solution interface. | 2007-06-15 |
|
| A spot test for ammonium ion by the color band formation method. | 2007-05-15 |
|
| Mixed micelle formation and solubilization behavior toward polycyclic aromatic hydrocarbons of binary and ternary cationic-nonionic surfactant mixtures. | 2007-03-29 |
|
| New insights on the photophysical behavior of PRODAN in anionic and cationic reverse micelles: from which state or states does it emit? | 2007-02-01 |
|
| Two-dimensional BAC/SDS-PAGE for membrane proteomics. | 2007 |
|
| Condensed film formation of binary mixtures of cetyltrimethylammonium bromide and cetyldimethylbenzylammonium chloride in a wide potential region at the mercury/electrolyte interface. | 2006-12-01 |
|
| Analysis of the synaptic vesicle proteome using three gel-based protein separation techniques. | 2006-12 |
|
| Comparative study of the photophysical behavior of fisetin in homogeneous media and in anionic and cationic reverse micelles media. | 2006-11-23 |
|
| Synaptic vesicle proteins under conditions of rest and activation: analysis by 2-D difference gel electrophoresis. | 2006-09 |
|
| Visual determination of nitrite and nitrate in waters by color band formation method. | 2006-09 |
|
| Equilibrium studies for the adsorption of acid dye onto modified hectorite. | 2006-08-25 |
|
| Enrichment of integral membrane proteins from small amounts of brain tissue. | 2006-08 |
|
| Mass spectrometrical identification of brain proteins including highly insoluble and transmembrane proteins. | 2006-08 |
|
| Water remediation by micelle-clay system: case study for tetracycline and sulfonamide antibiotics. | 2006-07 |
|
| Measuring quaternary ammonium cleaning agents with ion selective electrodes. | 2006-06-16 |
|
| Dechlorination of beta-methylallyl chloride by electrogenerated [Co(I)(bipyridine)3]+: an electrochemical study in the presence of cationic surfactants. | 2006-05-15 |
|
| Resonance Rayleigh scattering method for the determination of cationic surfactants with chromium(VI)-iodide system. | 2006-05 |
|
| Effect of the deaeration on the adsorption of some cationic surfactants at the mercury/electrolyte solution interface. | 2006-04-15 |
|
| Release characteristics of anionic drug compounds from liquid crystalline gels. Part II. The effects of ion pairing and buffering on the passive delivery of anionic drugs across non-rate-limiting membranes. | 2006-03-27 |
|
| Influence of absorption enhancers on the pharmacokinetic properties of non-oral beta-lactam-cefpirom using the rabbit (Chinchilla) in vivo model. | 2006-02-17 |
|
| A new multiphasic buffer system for benzyldimethyl-n-hexadecylammonium chloride polyacrylamide gel electrophoresis of proteins providing efficient stacking. | 2006-02 |
|
| Occupational contact dermatitis to Mikrobac Extra in 8 hospital cleaners. | 2006-01 |
|
| Immunoisolation of two synaptic vesicle pools from synaptosomes: a proteomics analysis. | 2005-12 |
|
| Identification of benzalkonium chloride in commercial grapefruit seed extracts. | 2005-09-21 |
|
| Two-dimensional benzyldimethyl-n-hexadecylammonium chloride/SDS-PAGE for membrane proteomics. | 2005-09 |
|
| On the adsorption of cetyldimethylbenzylammonium chloride at the mercury/electrolyte solution interface. | 2005-05-15 |
|
| Water purification from organic pollutants by optimized micelle-clay systems. | 2005-04-01 |
|
| Resonance Rayleigh scattering study of interaction of heparin with some cationic surfactants and their analytical application. | 2005-03 |
|
| The synaptic vesicle proteome: a comparative study in membrane protein identification. | 2004-10 |
|
| Static and dynamic light-scattering studies on micellar solutions of alkyldimethylbenzylammonium chlorides. | 2004-08-15 |
Patents
Sample Use Guides
Massage one centimetre of the topical formulation (Bonjela) onto the affected area (mouth ulcers and sores) and leave at least 30 min in case of denture sores. In dry eye disease, the recommended dose is one drop of the ocular formulation (Ikervis) once daily to be applied to the affected eye(s) at bedtime.
Route of Administration:
Other
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 08:32:14 GMT 2025
by
admin
on
Wed Apr 02 08:32:14 GMT 2025
|
| Record UNII |
85474O1N9D
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
EPA PESTICIDE CODE |
69108
Created by
admin on Wed Apr 02 08:32:14 GMT 2025 , Edited by admin on Wed Apr 02 08:32:14 GMT 2025
|
||
|
NCI_THESAURUS |
C28394
Created by
admin on Wed Apr 02 08:32:14 GMT 2025 , Edited by admin on Wed Apr 02 08:32:14 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
100000082068
Created by
admin on Wed Apr 02 08:32:14 GMT 2025 , Edited by admin on Wed Apr 02 08:32:14 GMT 2025
|
PRIMARY | |||
|
32942
Created by
admin on Wed Apr 02 08:32:14 GMT 2025 , Edited by admin on Wed Apr 02 08:32:14 GMT 2025
|
PRIMARY | |||
|
31202
Created by
admin on Wed Apr 02 08:32:14 GMT 2025 , Edited by admin on Wed Apr 02 08:32:14 GMT 2025
|
PRIMARY | |||
|
Cetalkonium chloride
Created by
admin on Wed Apr 02 08:32:14 GMT 2025 , Edited by admin on Wed Apr 02 08:32:14 GMT 2025
|
PRIMARY | |||
|
3078
Created by
admin on Wed Apr 02 08:32:14 GMT 2025 , Edited by admin on Wed Apr 02 08:32:14 GMT 2025
|
PRIMARY | |||
|
122-18-9
Created by
admin on Wed Apr 02 08:32:14 GMT 2025 , Edited by admin on Wed Apr 02 08:32:14 GMT 2025
|
PRIMARY | |||
|
m3286
Created by
admin on Wed Apr 02 08:32:14 GMT 2025 , Edited by admin on Wed Apr 02 08:32:14 GMT 2025
|
PRIMARY | Merck Index | ||
|
DTXSID3041665
Created by
admin on Wed Apr 02 08:32:14 GMT 2025 , Edited by admin on Wed Apr 02 08:32:14 GMT 2025
|
PRIMARY | |||
|
C77034
Created by
admin on Wed Apr 02 08:32:14 GMT 2025 , Edited by admin on Wed Apr 02 08:32:14 GMT 2025
|
PRIMARY | |||
|
85474O1N9D
Created by
admin on Wed Apr 02 08:32:14 GMT 2025 , Edited by admin on Wed Apr 02 08:32:14 GMT 2025
|
PRIMARY | |||
|
SUB07445MIG
Created by
admin on Wed Apr 02 08:32:14 GMT 2025 , Edited by admin on Wed Apr 02 08:32:14 GMT 2025
|
PRIMARY | |||
|
204-526-3
Created by
admin on Wed Apr 02 08:32:14 GMT 2025 , Edited by admin on Wed Apr 02 08:32:14 GMT 2025
|
PRIMARY | |||
|
C012817
Created by
admin on Wed Apr 02 08:32:14 GMT 2025 , Edited by admin on Wed Apr 02 08:32:14 GMT 2025
|
PRIMARY | |||
|
DBSALT001776
Created by
admin on Wed Apr 02 08:32:14 GMT 2025 , Edited by admin on Wed Apr 02 08:32:14 GMT 2025
|
PRIMARY | |||
|
85474O1N9D
Created by
admin on Wed Apr 02 08:32:14 GMT 2025 , Edited by admin on Wed Apr 02 08:32:14 GMT 2025
|
PRIMARY | |||
|
CHEMBL1624075
Created by
admin on Wed Apr 02 08:32:14 GMT 2025 , Edited by admin on Wed Apr 02 08:32:14 GMT 2025
|
PRIMARY | |||
|
1843
Created by
admin on Wed Apr 02 08:32:14 GMT 2025 , Edited by admin on Wed Apr 02 08:32:14 GMT 2025
|
PRIMARY | |||
|
47907
Created by
admin on Wed Apr 02 08:32:14 GMT 2025 , Edited by admin on Wed Apr 02 08:32:14 GMT 2025
|
PRIMARY | RxNorm |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |